FIELD: medicine.
SUBSTANCE: invention refers to producing fused proteins. The fused construct consists of an amino acid sequence of glycosyl phosphatidylinositol anchored tissue inhibitor of metalloproteinase.
EFFECT: cictrisation prevention during skin injures treatment when using the fused construct.
10 cl, 33 dwg, 18 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS AND METHODS FOR ANGIOGENESIS SUPPRESSION | 2010 |
|
RU2786127C2 |
METHOD FOR PREDICTION OF CLINICAL OUTCOMES OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS | 2009 |
|
RU2426991C2 |
DEVICES AND METHODS FOR SELECTION OF CELLS RESISTANT TO APOPTOTIC SIGNALS AND THEIR APPLICATIONS | 2013 |
|
RU2630301C2 |
ANTIBODY SELECTIVE TO RECEPTOR APOPTOSIS-INDUCING LIGAND AND ASSOCIATED WITH TUMOR NECROSIS FACTOR AND ITS USING | 2002 |
|
RU2313537C2 |
COMPOSITIONS AND METHODS FOR INHIBITION OF CELLULAR ADHESION OR DIRECTION OF DIAGNOSTIC OR THERAPEUTIC AGENTS TO RGD BINDING SITES | 2010 |
|
RU2642625C2 |
METHOD FOR PREDICTING THE COURSE OF CLEAR CELL RENAL CELL CARCINOMA | 2022 |
|
RU2792250C1 |
INTEGRIN RECEPTOR ANTAGONISTS AND USE THEREOF | 2012 |
|
RU2721907C2 |
METHODS AND COMPOSITIONS APPLICABLE FOR MODULATION OF ANTIOGENESIS USING PROTEIN KINASES RAF AND RAS | 2000 |
|
RU2257911C2 |
ANTI-AXL ANTIBODIES | 2008 |
|
RU2506276C2 |
POLYPEPTIDE WITH GROWTH HORMONE RECEPTOR AGONIST PROPERTIES, NUCLEIC ACID CODING SAID POLYPEPTIDE, EXPRESSION VECTOR THEREOF AND CELL PRODUCING SAID POLYPEPTIDE | 2005 |
|
RU2391353C2 |
Authors
Dates
2011-09-10—Published
2006-09-20—Filed